Carcinoid Syndrome: Clinical Trials

2 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	2	Terminated 2
Phase 1	1	Terminated 1

Follow Carcinoid Syndrome: new trials by email Literature Review of Carcinoid Syndrome trials Research Report on Carcinoid Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome BIM 23A760 - Carcinoid Syndrome	Phase 2	Terminated	Ipsen	8	2010-02-01	2020-11-20
Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome Octreotide - Carcinoid Syndrome	Phase 1 / Phase 2	Terminated	Endo USA Inc., a Keenova Therapeutics Company	10	2009-07-01	2013-09-20

Narrower conditions

Serotonin Syndrome (2)

Broader conditions

Chemically-Induced Disorders (2)  ·  Drug-Related Side Effects and Adverse Reactions (2)

Interventions

Octreotide (1)  ·  TBR-760 (1)

Sponsors

Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Ipsen (1)

Countries

Austria (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Latvia (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  Slovakia (1)  ·  Spain (1)

NIH funding

2009 (1)